Signal active
Bio
Dr. Misawa is currently one of the directors of investment group in Japan Asia Investment Co., Ltd. (JAIC). With over 10 years' experience in healthcare investment, he leads biotech, medical device and medical service investments in JAIC and is a member of investment committee of a fund of funds in JAIC which invest to top tier Life Science VCs in Europe.
He also plays a major role as investment committee member of some JAIC's investment funds in China. Prior to join JAIC group, Dr. Misawa held academic position as an assistant professor at Kurume University and University of Shizuoka, and a visiting research fellow at Baylor College of Medicine for 7 years. He received his BS, MS and PhD degrees in Biochemistry from Saitama University.
Location
Tokyo, Tokyo, Japan, Asia
Social
Primary Organization
1981
65
12
20
11-50
Financial Services, Venture Capital, Web Hosting, Business Development
Jobs history
3
ARTham Therapeutics
Director
Invalid date - Current
Integral Geometry Science
Auditor
Invalid date - Current
iHeart Japan
Director
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Hiroyuki Misawa is the Managing Director at Japan Asia Investment, based in Asia. With a background in Financial Services, Hiroyuki Misawa has a rich history of leadership and innovation. Hiroyuki Misawa studied BS unknown @ Saitama University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
6
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
May 10, 2017 | REGiMMUNE | Series E - REGiMMUNE | Japan Asia Investment | 5.7M |
Jul 10, 2018 | ARTham Therapeutics | Series A - ARTham Therapeutics | Miyako Capital | 0 |
Mar 15, 2021 | VLP Therapeutics | Series A - VLP Therapeutics | Miyako Capital | 16.0M |
Dec 27, 2021 | VLP Therapeutics | Series A - VLP Therapeutics | Miyako Capital | 21.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.